Breast cancer survival prediction using machine learning and multimodal data for personalized care plan
Nasibeh Rady Raz1,2, Nahid Nafissi3,4,5, Ebrahim Babaee6
1Breast Cancer Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. radyraz.n@iums.ac.ir.
BMC Cancer
|June 2, 2026
Summary
Machine learning models predict breast cancer survival rates using patient data. XGBoost achieved over 90% accuracy, identifying key predictors like DCIS and Ki-67 for personalized treatment planning.
Area of Science:
- Oncology
- Biostatistics
- Machine Learning
Background:
- Accurate breast cancer survival prediction is crucial for personalized treatment planning.
- Existing models may not fully capture complex, time-dependent patient and tumor characteristics.
Purpose of the Study:
- To develop and validate time-stratified breast cancer survival prediction models using machine learning.
- To identify key predictors of long-term survival using explainable AI techniques.
Main Methods:
- Utilized multimodal data from 3,476 breast cancer patients with 43 features.
- Applied six machine learning algorithms (XGBoost, Logistic Regression, Random Forest, Decision Tree, AdaBoost, Multilayer Perceptron) for survival rate prediction.
- Employed Shapley Additive exPlanations (SHAP) for model interpretability and feature importance analysis.
Main Results:
- XGBoost demonstrated superior performance with over 90% accuracy.
- Top predictors for longer survival included lower DCIS, lower Ki-67, lower lymph node/tumor grade, higher age, and longer breastfeeding duration.
- SHAP analysis provided detailed insights into factors influencing survival across different time points.
Conclusions:
- Machine learning, particularly XGBoost, offers a powerful tool for accurate breast cancer survival prediction.
- Explainable AI (SHAP) reveals critical clinical, molecular, and demographic factors that can guide personalized treatment strategies.
- The study provides valuable insights for improving patient care and outcomes in breast cancer management.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
